Our findings indicate that potentiating the activity of NGF at the level of RhoA inactivation and PTP1B activation may represent a new means to combat the noxious effects of Aβ in Alzheimer's disease. The gene discussed is RHOA; the disease is early-onset autosomal dominant Alzheimer disease.